1-(3-Hydroxypropyl)-5-(2-((2-(2,4,6-trimethylphenoxy)ethyl)-amino)propyl)indoline-7-carboxamide

ID: ALA3809500

PubChem CID: 123752717

Max Phase: Preclinical

Molecular Formula: C26H37N3O3

Molecular Weight: 439.60

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1

Standard InChI:  InChI=1S/C26H37N3O3/c1-17-12-18(2)25(19(3)13-17)32-11-7-28-20(4)14-21-15-22-6-9-29(8-5-10-30)24(22)23(16-21)26(27)31/h12-13,15-16,20,28,30H,5-11,14H2,1-4H3,(H2,27,31)

Standard InChI Key:  GEJDAWYRSPAFCX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6187    1.4919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6267    2.9927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9300    3.7369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5905    3.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9380    5.2378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2413    5.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2494    7.4828    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5527    8.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5629    9.7271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8670   10.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1609    9.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1508    8.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8467    7.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1855   -2.6254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6552   -2.9294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1277   -4.3539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3028   -4.5970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9971   -3.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0337   -3.6184    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0446   -3.6095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8386    6.2684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2042   10.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5278   10.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  1 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  7 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
  3 27  1  0
 27 28  2  0
 27 29  1  0
 22 30  1  0
 20 31  1  0
 18 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3809500

    ---

Associated Targets(Human)

ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.60Molecular Weight (Monoisotopic): 439.2835AlogP: 3.06#Rotatable Bonds: 11
Polar Surface Area: 87.82Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.73CX LogP: 3.79CX LogD: 1.51
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.47Np Likeness Score: -0.55

References

1. Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H..  (2016)  Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective α1A-Adrenoceptor Antagonists.,  59  (8): [PMID:27031406] [10.1021/acs.jmedchem.5b02023]

Source